U.S. Logistics Stock News

NYSE:LAD
NYSE:LADSpecialty Retail

Is It Time To Reconsider Lithia Motors (LAD) After Recent Auto Retail Growth Ambitions News

With Lithia Motors trading at around US$274.48, this article examines whether the current share price points more toward opportunity or risk, and what it may be implying about the company. The stock has moved 4.3% over the last 7 days and 8.7% over the last 30 days, while year to date it shows a 17.4% decline and a 2.3% decline over the last year. This is set against a 26.7% gain over 3 years and a 26.2% decline over 5 years. Recent news coverage has highlighted Lithia Motors as a key name...
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

Gilead’s Lenacapavir Access Push And Pricing Protests Shape HIV Outlook

Gilead Sciences has launched a global health partnership with the U.S. State Department, PEPFAR, and The Global Fund to expand access to its twice yearly injectable HIV prevention drug, lenacapavir, in sub Saharan Africa. The company plans to supply lenacapavir at no profit under this initiative, with a goal of reaching up to 1,000,000 additional people by 2028 and paving the way for future generics. At the same time, Gilead is facing protests at its headquarters led by the AIDS Healthcare...
NasdaqGS:LITE
NasdaqGS:LITECommunications

Is It Too Late To Consider Lumentum Holdings (LITE) After Its Recent Surge In 2024?

If you are wondering whether Lumentum Holdings at around US$824.01 is priced for perfection or still offers value, it helps to step back from the headline share price and look at what the fundamentals suggest. The stock has been volatile recently, with a 31.9% gain over the last month, a 113.4% return year to date, and a 7 day return of an 8% decline, while the 1 and 3 year returns are very large on a multiple basis. Recent coverage of Lumentum has focused on its role in the broader...
NasdaqGS:SVRA
NasdaqGS:SVRABiotechs

A Look At Savara (SVRA) Valuation After Strong 1 Year Shareholder Return

Recent share performance and business profile Savara (SVRA) has drawn attention after a month return of about 12%, following a relatively flat past 3 months. The move comes as investors reassess this US$1.5b clinical stage rare disease developer. See our latest analysis for Savara. Despite a softer 1-day share price return of 3.29% and a 7-day share price return of 1.18%, Savara’s 12.24% 30-day share price return sits alongside a very large 1-year total shareholder return of around 100%,...
NasdaqGS:GPRE
NasdaqGS:GPREOil and Gas

Is It Too Late To Consider Green Plains (GPRE) After A 343% One Year Surge?

Wondering if Green Plains at US$15.41 still offers value after a huge run, or if most of the opportunity is already priced in. The stock has returned 49.9% year to date and 342.8% over the past year, even though the 3 year and 5 year returns of 53.6% and 35.3% are negative. Recent attention on Green Plains has centered on its position in the broader energy space and how investors are reassessing companies exposed to changing fuel and commodity trends. That shift in focus helps explain why...
NYSE:ASAN
NYSE:ASANSoftware

Assessing Asana (ASAN) Valuation After Recent Share Price Rebound

What Asana’s recent share move could mean for investors Asana (ASAN) shares recently moved to about $6.08, leaving the stock with a negative return over the past month and past 3 months. This performance may prompt investors to reassess expectations and risk tolerance. See our latest analysis for Asana. That 10.75% 1 day share price gain to $6.08 comes after a 30 day share price return of 10.46% and a 90 day share price return of 47.18%. The 1 year total shareholder return of 59.57% and 5...
NasdaqCM:MARA
NasdaqCM:MARASoftware

Why MARA Holdings (MARA) Is Up 10.2% After Pivoting Bitcoin Proceeds Into AI Infrastructure And Debt

In recent weeks, MARA Holdings sold 15,133 bitcoin for about US$1.10 billion and used roughly US$1.00 billion of the proceeds to repurchase 0.00% convertible senior notes at a discount, while outlining a shift from pure bitcoin mining toward AI and high-performance computing infrastructure. This move both reshapes the balance sheet and repurposes mining sites into AI-capable data centers, signalling an effort to align its operations with growing digital energy and compute demand while...
NasdaqGM:PRCT
NasdaqGM:PRCTMedical Equipment

PROCEPT BioRobotics (PRCT) Is Up 7.5% After Raising 2026 Revenue Outlook And Sharpening Growth Focus

In the past quarter, PROCEPT BioRobotics reported strong third-quarter 2025 execution and issued fiscal 2026 revenue expectations of US$410 million to US$430 million, while management detailed organizational changes to accelerate new account launches and boost therapy awareness. Beyond the headline numbers, the company’s emphasis on improving procedure utilization to unlock longer-term value highlights how management is targeting deeper engagement within its existing customer base rather...
NasdaqGS:PTON
NasdaqGS:PTONLeisure

Is It Time To Reassess Peloton (PTON) After The Recent 25% Monthly Share Price Jump

Wondering whether Peloton Interactive's current share price reflects its true potential or too much hope? This article walks through what the latest valuation work is really saying about the stock. After years of weak long term returns, Peloton's share price recently moved 4.7% over the last week and 25.6% over the last month. This comes even though the year to date return stands at a 20.6% decline and the 1 year return is a 13.5% decline. Recent headlines around Peloton have largely focused...
NYSE:QBTS
NYSE:QBTSSoftware

Nvidia Quantum AI Models Put Focus On D-Wave Quantum’s Growth Prospects

Nvidia has launched the open source Ising family of AI models, built to support quantum error correction and calibration for quantum hardware. The launch has coincided with a broad move in quantum computing stocks, bringing fresh attention to commercial use cases across the sector. D-Wave Quantum (NYSE:QBTS) has responded publicly, with CEO Alan Baratz outlining how the company expects its quantum annealing and gate-model platforms to compete in energy efficient quantum processing. D-Wave...
NYSE:SHAK
NYSE:SHAKHospitality

Rob Lynch’s Early Operational Wins Might Change The Case For Investing In Shake Shack (SHAK)

In recent days, Shake Shack has drawn fresh attention as analysts and commentators highlighted improving unit economics, operational efficiencies, and digital initiatives under CEO Rob Lynch’s leadership. What stands out is how confidence in Lynch’s early impact, combined with expected benefits from marketing, app adoption, and a forthcoming loyalty program, is reshaping expectations for the business. Next, we’ll explore how growing optimism around Rob Lynch’s leadership and operational...
NYSE:FAF
NYSE:FAFInsurance

A Look At First American Financial (FAF) Valuation After Mixed Recent Share Price Performance

Why First American Financial is on investors’ radar First American Financial (FAF) has drawn fresh attention after recent price moves left the stock with a mixed short term record, including a month return in negative territory alongside a positive past 3 months performance. For investors watching insurance and real estate exposed names, those different return snapshots are prompting closer scrutiny of how First American Financial’s current share price compares with its recent track record...
NasdaqGS:MDLZ
NasdaqGS:MDLZFood

Should Earnings Pressure and Inflation Risks Require Action From Mondelez International (MDLZ) Investors?

In recent days, Mondelez International has drawn attention ahead of its fiscal first-quarter earnings release, with analysts forecasting a double-digit drop in profit and some institutional investors cutting their holdings in the stock. At the same time, research firms have issued differing views on the company’s ability to handle cost pressures and sustain performance, highlighting uncertainty around its near-term outlook. We’ll now examine how the expected earnings decline and inflation...
NYSE:RCL
NYSE:RCLHospitality

Royal Caribbean Leans Into Luxury With Silversea 2029 World Cruise

Silversea, the luxury brand of Royal Caribbean Group, has announced its 2029 World Cruise. The 125 day Pacific journey focuses on high end experiences and access to rare destinations. The itinerary is positioned to appeal to affluent travelers seeking longer, immersive cruises. For investors watching Royal Caribbean Cruises (NYSE:RCL), this move highlights the group’s push further into the luxury segment through Silversea. High end, experience focused sailings such as a 125 day World Cruise...
NYSE:FNB
NYSE:FNBBanks

Assessing F.N.B Corporation (FNB) Valuation After Dividend Hike And $250 Million Buyback Authorization

Why F.N.B (FNB) is in focus today F.N.B (FNB) is back on investors' radar after its Board approved an 8% lift in the quarterly dividend to $0.13 per share and authorized a new $250 million share repurchase program. See our latest analysis for F.N.B. The dividend and buyback news comes after a period of steady share price gains, with a 30 day share price return of 11.6% and a 1 year total shareholder return of 50.8%. This suggests momentum has been building rather than fading. If this kind of...
NYSE:CCL
NYSE:CCLHospitality

Is It Too Late To Consider Carnival (CCL) After Its Strong Share Price Recovery?

Wondering whether Carnival Corporation & at around US$28.82 is still good value after its recovery, or if most of the upside is already priced in. The stock price has moved 2.8% over the last 7 days and 16.6% over the last 30 days, with a 1 year return of 62.0% and a 3 year return of around 195.4%, even as year to date performance sits at a 6.8% decline and the 5 year return is 5.9%. Recent headlines have focused on Carnival Corporation & as a key name in the cruise sector recovery story,...
NasdaqGS:STOK
NasdaqGS:STOKBiotechs

Did Stoke's New R&D Chair Appointment Just Reshape Stoke Therapeutics' (STOK) Antisense Strategy Priorities?

Earlier in April 2026, Stoke Therapeutics expanded its Board of Directors to ten members and appointed G. Clare Kahn, Ph.D., a veteran of Pfizer, GlaxoSmithKline and X-VAX, as a Class I director and chair of the Board’s Research and Development Committee. Her combination of deep regulatory, preclinical and lifecycle management experience could meaningfully influence how Stoke prioritizes and advances its antisense pipeline for severe genetic diseases. Next, we’ll consider how Dr. Kahn’s...
NasdaqGS:IREN
NasdaqGS:IRENSoftware

A Look At IREN (NasdaqGS:IREN) Valuation After Its Recent Share Price Surge

What recent performance says about IREN Without a single headline event driving attention, IREN (NasdaqGS:IREN) has still caught investor interest after a 3.1% move in the latest session and a 32.6% gain over the past week. See our latest analysis for IREN. The recent 32.6% 7 day share price return comes after a quieter 1 month share price move of 8.6%. The 1 year total shareholder return is roughly 8x and the 3 year total shareholder return is a little above 10x, which hints that momentum...
NYSE:FLR
NYSE:FLRConstruction

How Investors May Respond To Fluor (FLR) Winning New US Refinery and Advanced Nuclear Contracts

Fluor Corporation recently announced two new US energy assignments: front-end engineering and design for America First Refining’s planned large-scale Brownsville, Texas refinery, and FEL-2 services for X-energy’s advanced nuclear project at Dow’s Seadrift operations, with both undisclosed contracts to be recognized in first-quarter 2026. These wins highlight Fluor’s dual role in supporting conventional fuels and advanced nuclear power, reinforcing its position across diverse US energy...
NYSE:STWD
NYSE:STWDMortgage REITs

A Look At Starwood Property Trust (STWD) Valuation As Opinions On Its True Worth Diverge

Why Starwood Property Trust Is on Investors’ Radar Today Starwood Property Trust (STWD) is drawing fresh attention after its recent trading performance, with the stock showing mixed short term moves, alongside a positive 1 year total return and multi year total returns that some income investors are reviewing closely. See our latest analysis for Starwood Property Trust. At a share price of $18.15, the stock has seen a 3.5% 1 month share price return and a modest year to date share price...
NasdaqGS:CME
NasdaqGS:CMECapital Markets

Does New Eris SOFR Swap Options Launch Reshape the Bull Case For CME Group (CME)?

CME Group has announced it will launch options on Eris SOFR Swap futures on June 16, 2026, pending regulatory review, adding options on 2-year, 5-year and 10-year contracts that are designed to replicate interest rate swap cash flows while offering margin offsets with other cleared interest rate products at CBOT. This expansion builds on growing use of Eris SOFR Swap futures, which have surpassed 10 million contracts traded and set an all-time open interest record of 707,000 contracts, and...
NYSE:OVV
NYSE:OVVOil and Gas

A Look At Ovintiv (OVV) Valuation As Analysts See Shares Modestly Undervalued

Ovintiv (OVV) has drawn fresh attention after recent trading left the stock at $55.04, with a value score of 6 and a market cap near US$15.5b, prompting closer scrutiny from income- and value-focused investors. See our latest analysis for Ovintiv. Recent trading has been choppy, with a 1-day share price return of 0.44% and a 7-day share price return of negative 3.06%, set against a stronger 90-day share price return of 37.77% and a 1-year total shareholder return of 70.93%. This points to...
NasdaqCM:SEZL
NasdaqCM:SEZLDiversified Financial

Sezzle’s Canadian Virtual Card Tests BNPL Growth And Risk Control

Sezzle (NasdaqCM:SEZL) has launched its Virtual Card in Canada, powered by Marqeta. The roll out extends Sezzle’s Buy Now, Pay Later offering to a new geography and broadens where consumers can use the service. This move opens additional opportunities for participating merchants to offer installment payments at more checkout locations. For readers tracking the Buy Now, Pay Later space, this Canadian launch gives more detail on how Sezzle is building out its product set and footprint. The...